Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 10, 2007New England Journal of MedicineOpen Access

Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine

View Full Paper
Ask AI
Bookmark
Share

Authors

SLShahin LockmanBrigham and Women's HospitalRSRoger ShapiroHarvard UniversityLSLaura SmeatonCancer Research And Biostatistics

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lockman et al. (2007) studied this question.

synapsesocial.com/papers/6a7d8697603f5e16dd33965ahttps://doi.org/10.1056/nejmoa062876
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quantitative Analysis of HIV-1 Variants With the K103N Resistance Mutation After Single-Dose Nevirapine in Women With HIV-1 Subtypes A, C, and D2006 · 88 citations
  2. 2Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission2006 · 109 citations
  3. 3Breast‐Milk Shedding of Drug‐Resistant HIV‐1 Subtype C in Women Exposed to Single‐Dose Nevirapine2005 · 62 citations
  4. 4Intrapartum and Neonatal Single-Dose Nevirapine Compared With Zidovudine for Prevention of Mother-to-Child Transmission of HIV-1 in Kampala, Uganda: 18-Month Follow Up of the HIVNET 012 Randomized Trial2004 · 50 citations
  5. 5Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial1999 · 1,652 citations